New advances in pharmaceutical strategies for sensitizing anti-PD-1 immunotherapy and clinical research.
Sign Up to like & getrecommendations! Published in 2022 at "Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology"
DOI: 10.1002/wnan.1837
Abstract: Attempts have been made continuously to use nano-drug delivery system (NDDS) to improve the effect of antitumor therapy. In recent years, especially in the application of immunotherapy represented by antiprogrammed death receptor 1 (anti-PD-1), it… read more here.
Keywords: anti immunotherapy; advances pharmaceutical; pharmaceutical strategies; new advances ... See more keywords
Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2022.121507
Abstract: Respiratory infections are one of the major global health problems. Among them, chronic respiratory infections caused by biofilm formation are difficult to treat because of both drug tolerance and poor drug penetration into the complex… read more here.
Keywords: combating respiratory; respiratory biofilm; nanotechnology; pharmaceutical strategies ... See more keywords
Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.1080/14756366.2021.2020773
Abstract: Abstract Bilirubin (BR) is the final product of haem catabolism. Disruptions along BR metabolic/transport pathways resulting from inherited disorders can increase plasma BR concentration (hyperbilirubinaemia). Unconjugated hyperbilirubinemia may induce BR accumulation in brain, potentially causing… read more here.
Keywords: preventing toxicity; antioxidant anti; strategies preventing; pharmaceutical strategies ... See more keywords